Exhaled HPV infection in lung cancer: role of MA at 3p

Giovanna E Carpagnano1, Donato Lacedonia1, Elisabetta Crisetti1

  • 1Department of Medical and Surgical Sciences, Institute of Respiratory Disease, University of Foggia, Foggia, Italy.

Abstract

Insights

Microsatellite alterations (MAs) at 3p are present in the exhaled breath condensate of non-small cell lung cancer (NSCLC) patients positive for human papilloma virus (HPV). These MAs may play a role in lung carcinogenesis and could be useful for non-invasive screening.

Area of Science:

  • Oncology
  • Genetics
  • Virology

Background:

  • Human papilloma virus (HPV) infection is increasingly linked to lung cancer development.
  • HPV DNA integration into the host genome is a critical event in oncogenesis.
  • Fragile sites like FRA3B, near FHIT, are prone to microsatellite alterations (MAs) upon HPV integration.

Purpose of the Study:

  • To investigate the role of MAs at chromosomal region 3p in non-small cell lung cancer (NSCLC) with HPV positivity.
  • To explore correlations between 3p MAs and clinical factors such as sex, histotype, TNM stage, and smoking status.

Main Methods:

  • Allelotyping analysis of microsatellite D3S1300 at 3p was performed on DNA from exhaled breath condensate (EBC), blood, and bronchial brushing.
  • 26 NSCLC patients were analyzed, categorized into HPV-positive (11) and HPV-negative (15) groups.

Main Results:

  • The study identified MAs at 3p in the EBC of HPV-positive NSCLC patients for the first time.
  • MAs detected in EBC samples corresponded with those in paired bronchial brushing samples.
  • A higher prevalence of 3p MAs was observed in HPV-positive NSCLC patients compared to HPV-negative patients.
  • No significant correlation was found between MAs and patient sex, histotype, or tumor stage.

Conclusions:

  • MAs at 3p are present in Caucasian NSCLC patients with HPV positivity and may contribute to lung carcinogenesis.
  • Analysis of 3p MAs in EBC of HPV-positive patients shows potential for non-invasive lung cancer screening.
  • Further research is warranted to validate the clinical utility of 3p MA analysis in EBC for lung cancer detection.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
MicroRNAs01:22

MicroRNAs

9.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K